Multidrug-Resistant Acinetobacter baumanii and Pseudomonas aeruginosa

被引：0
|
作者：
Hsueh, Po-Ren [1 ]
机构：
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [21] Novel therapies of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp. infections:: the state of the art
    Wroblewska, M
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (02) : 113 - 120
  • [22] Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa
    Sabuda, Deana M.
    Laupland, Kevin
    Pitout, Johann
    Dalton, Bruce
    Rabin, Harvey
    Louie, Thomas
    Conly, John
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2008, 19 (06): : 413 - 418
  • [23] Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    Coyne, Ashlan J. Kunz
    El Ghali, Amer
    Holger, Dana
    Rebold, Nicholas
    Rybak, Michael J.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 661 - 682
  • [24] Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa
    Miyoshi-Akiyama, Tohru
    Tada, Tatsuya
    Ohmagari, Norio
    Nguyen Viet Hung
    Tharavichitkul, Prasit
    Pokhrel, Bharat Mani
    Gniadkowski, Marek
    Shimojima, Masahiro
    Kirikae, Teruo
    GENOME BIOLOGY AND EVOLUTION, 2017, 9 (12): : 3238 - 3245
  • [25] Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    Ashlan J. Kunz Coyne
    Amer El Ghali
    Dana Holger
    Nicholas Rebold
    Michael J. Rybak
    Infectious Diseases and Therapy, 2022, 11 : 661 - 682
  • [26] Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin
    A. Safarika
    I. Galani
    A. Pistiki
    E. J. Giamarellos-Bourboulis
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 317 - 323
  • [27] The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
    Mwangi, James
    Yin, Yizhu
    Wang, Gan
    Yang, Min
    Li, Ya
    Zhang, Zhiye
    Lai, Ren
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (52) : 26516 - 26522
  • [28] Silver Nanocomposite Biosynthesis: Antibacterial Activity against Multidrug-Resistant Strains of Pseudomonas aeruginosa and Acinetobacter baumannii
    Santos, Klebson Silva
    Barbosa, Andriele Mendonca
    da Costa, Luiz Pereira
    Pinheiro, Malone Santos
    Prior Pinto Oliveira, Maria Beatriz
    Padilha, Francine Ferreira
    MOLECULES, 2016, 21 (09)
  • [29] Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline
    Somily, Ali M.
    Absar, Muhammad M.
    Arshad, Muhammad Z.
    Al Aska, Abdulkarim I.
    Shakoor, Zahid A.
    Fatani, Amal J.
    Siddiqui, Yunus M.
    Murray, Thomas S.
    SAUDI MEDICAL JOURNAL, 2012, 33 (07) : 750 - 755
  • [30] Salvage Therapy with CeftolozaneTazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
    Jose Caston, Juan
    De la Torre, Alvaro
    Ruiz-Camps, Isabel
    Luisa Sorli, Maria
    Torres, Vicente
    Torre-Cisneros, Julian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
12345